The Motley Fool

Looking for dividend stocks for retirement? I think you’ll love these FTSE 100 companies

Image source: Getty Images.

Investing in retirement is all about balance. On one hand, you want stocks that will help you grow your wealth over time and also provide income. On the other, you want to avoid taking big risks with your capital as your retirement lifestyle is at stake. 

With that in mind, here’s a look at two FTSE 100 dividend stocks that I believe are well suited to those in retirement. In my view, both companies have the potential to deliver a nice mix of capital gains and dividends going forward, yet are not too risky.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

A ‘sleep-well-at-night’ stock

If you’re looking for dividend stocks for retirement, it’s hard to look past consumer goods champion Unilever (LSE: ULVR) in my opinion.

For starters, the stock is relatively recession-proof. People buy Unilever products such as Dove soap and Persil detergent no matter whether the economy is flying or tanking. So, it’s a ‘sleep-well-at-night’ type stock.

Secondly, the group has significant exposure to emerging markets countries such as India and Brazil (emerging markets represent around 60% of sales), which means there’s an attractive long-term growth story. In a decade’s time, I expect sales to be far higher than they are today.

Thirdly, the company is a reliable dividend payer that has a very impressive dividend growth track record. And analysts expect the company to continue lifting its payout in the years ahead.

ULVR shares have experienced a significant pullback recently on the back of sterling strength and lower growth in the emerging markets. For long-term investors, I think this is an excellent buying opportunity. The prospective yield on offer is currently around 3.5%.

A play on the world’s ageing population

GlaxoSmithKline (GSK) is another FTSE 100 dividend stock that I believe is well suited to retirement portfolios. It’s a healthcare business that specialises in pharmaceuticals, vaccines, and consumer healthcare products such as painkillers and toothpaste.

What I like about GSK is that, like Unilever, it’s quite defensive in nature. During economic downturns, spending on healthcare tends to remain quite robust.

I also like the fact that the group is well positioned to benefit from the world’s ageing population. As people age, their demand for healthcare products such as painkillers tends to rise. Given that Glaxo owns a number of trusted brands in this space such as Voltaren, Panadol, and Fenbid (sold in China), I see an attractive long-term growth story.

Of course, you can’t discuss GSK without mentioning the big dividend on offer. Currently, GSK is paying out 80p per share in dividends per year, which equates to a yield of around 4.5% at the current share price. That’s certainly attractive in today’s low interest rate environment.

GSK shares have had a good run in recent months on the back of a strong third-quarter trading update in which the company upgraded its full-year earnings guidance. As a result, the stock isn’t as cheap as it was earlier in the year. I wouldn’t let the recent share price rise put you off buying though. I believe there’s still plenty of value left on the table.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Edward Sheldon owns shares in Unilever and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.